Insider Trading & Ownership of Redmile Group, LLC

Location
San Francisco, CA
Summary
The estimated value of insider holdings of Redmile Group, LLC is at least $699,452,137 dollars as of 28 Oct 2025. Redmile Group, LLC is the Director, 10%+ Owner of MedAvail Holdings, Inc. and owns shares of MedAvail Holdings, Inc. stock worth about $330.95M. Redmile Group, LLC is the 10%+ Owner of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $139.78M. Redmile Group, LLC is the Director, 10%+ Owner of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $45.74M. Redmile Group, LLC is the Director of Absci Corp and owns shares of Absci Corp (ABSI) stock worth about $41.14M. Redmile Group, LLC is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. stock worth about $33.44M. Redmile Group, LLC is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $31.25M. Redmile Group, LLC is the 10%+ Owner of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $30.58M. Redmile Group, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $19.37M. Redmile Group, LLC is the 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $13.39M. Redmile Group, LLC is the Director, 10%+ Owner of Shattuck Labs, Inc. and owns shares of Shattuck Labs, Inc. (STTK) stock worth about $6.92M. Redmile Group, LLC is the Director, 10%+ Owner of IGM Biosciences, Inc. and owns shares of IGM Biosciences, Inc. (IGMS) stock worth about $3.53M. Redmile Group, LLC is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $3.36M.
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
All Insider Reports
All Insider Reports

Notify me when Redmile Group, LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Redmile Group, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDVL MedAvail Holdings, Inc. Director, 10%+ Owner $330,947,442 16 Jun 2023
ADCT ADC Therapeutics SA 10%+ Owner $139,775,400 +$126,780,681 +976% 27 Oct 2025
FATE FATE THERAPEUTICS INC Director, 10%+ Owner $45,742,159 29 May 2025
ABSI Absci Corp Director $41,142,959 12 Jun 2024
RYZB RayzeBio, Inc. 10%+ Owner $33,438,708 19 Sep 2023
TRDA Entrada Therapeutics, Inc. 10%+ Owner $31,251,176 02 Nov 2021
ZYME Zymeworks Inc. 10%+ Owner $30,584,956 13 Oct 2022
VERV Verve Therapeutics, Inc. 10%+ Owner $19,365,300 21 Jun 2021
IVVD Invivyd, Inc. 10%+ Owner $13,394,292 10 Aug 2021
STTK Shattuck Labs, Inc. Director, 10%+ Owner $6,924,655 25 Aug 2025
IGMS IGM Biosciences, Inc. Director, 10%+ Owner $3,528,163 14 Aug 2025
ATRA Atara Biotherapeutics, Inc. Director $3,356,927 16 May 2025
AUGX Augmedix, Inc. Director, 10%+ Owner $0 02 Oct 2024
SNCE Science 37 Holdings, Inc. Former 10% Owner and Director $0 12 Mar 2024

Insider Transactions Reported by Redmile Group, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.